StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Seattle Genetics (SGEN) Adcetris Price Raised 3.9% - SunTrust Robinson Humphrey
January 2, 2018 1:19 PM
SunTrust Robinson Humphrey analyst Suneja Yatin highlighted that third party data showed that Seattle Genetics (NASDAQ: SGEN) increased the U.S ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Seattle Genetics (SGEN) Grantred FDA Supplemental Biologics License Application and Grants Priority Review for ADCETRIS (Brentuximab Vedotin)
January 2, 2018 8:01 AM